Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Neurochem Res. 2011 May;36(5):870-8. doi: 10.1007/s11064-011-0417-2. Epub 2011 Feb 4.
Nuclear factor erythroid 2-related factor 2 (Nrf2) coordinates the up-regulation of cytoprotective genes via the antioxidant response element (ARE). There is significant evidence that oxidative stress is a critical event in the pathogenesis of AD. Considering the protective role of Nrf2 against oxidative injury, we studied to determine whether in vivo toxicity of amyloid β (Aβ) can be attenuated by tBHQ, an Nrf2 stabilizer, Using an Aβ injection model. We demonstrated that pre-activation of endogenous Nrf2 by tBHQ attenuated Aβ-induced caspase-3 expression. tBHQ enhanced GSH, decreased MDA level, and inhibited NF-κB. This investigation provides the first documentation of tBHQ's neuroprotective effect through decrease of Aβ accumulation in rat brain. Our results show the involvement of Hsp-70 in this protective effect. In summary tBHQ treatment for 1 week prior to Aβ injection protected against the oxidative damage, apoptosis and Aβ accumulation in rats.
核因子红细胞 2 相关因子 2(Nrf2)通过抗氧化反应元件(ARE)协调细胞保护基因的上调。有大量证据表明,氧化应激是 AD 发病机制中的一个关键事件。鉴于 Nrf2 对氧化损伤的保护作用,我们研究了 Nrf2 稳定剂 tBHQ 是否可以减轻 Aβ 的体内毒性,使用 Aβ 注射模型。我们证明,tBHQ 预先激活内源性 Nrf2 可减轻 Aβ 诱导的 caspase-3 表达。tBHQ 增加 GSH,降低 MDA 水平,并抑制 NF-κB。这项研究首次证明了 tBHQ 通过减少大鼠脑中 Aβ 的积累来发挥神经保护作用。我们的结果表明 Hsp-70 参与了这种保护作用。总之,在 Aβ 注射前用 tBHQ 治疗 1 周可防止大鼠氧化损伤、细胞凋亡和 Aβ 积累。